UH Zaveri Limited has announced the appointment of Mr. Ritesh Soni as Company Secretary and Compliance Officer, effective December 31, 2025. The appointment was approved by the Board of Directors during their meeting held on December 31, 2025, following recommendations from the Nomination and Remuneration Committee.

Board Meeting and Regulatory Communication

The Board of Directors meeting was conducted on December 31, 2025, at the company's registered office to address the appointment of a new Company Secretary and Compliance Officer. The company formally communicated this decision to BSE Limited through an official letter signed by Managing Director Mr. Hitesh Mahendrakumar Shah (DIN: 07907609). The communication was addressed to the General Manager of the Listing Corporate Relations Department at BSE Limited's Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai.

Appointee Profile and Qualifications

CS Ritesh Soni is an Associate Member of the Institute of Company Secretaries of India with extensive experience in handling matters related to the Companies Act, Listing Regulations, and allied laws. The company confirmed that none of the Key Managerial Personnel (KMP), Senior Management, or directors are inter-se related to Mr. Soni, ensuring independence in the appointment.

Regulatory Compliance Framework

UH Zaveri Limited has informed BSE Limited about this key managerial appointment in strict compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also adhered to SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023, by providing comprehensive disclosure details through Annexure-A as part of Schedule III requirements.

This appointment ensures continuity in the company's compliance functions and strengthens the corporate governance framework. The formal communication to BSE was digitally signed and submitted on the same day as the board meeting, demonstrating prompt regulatory compliance and transparency in corporate governance practices.

UH Zaveri Limited has unveiled the terms of its upcoming rights issue, aiming to raise up to ₹20.39 crore through the offering of new equity shares. The company's board of directors approved the issuance details in a meeting held on September 22, 2025, following the in-principle approval received from BSE Limited on July 31, 2025.

Rights Issue Details

The rights issue offers existing shareholders the opportunity to purchase additional shares in the company at a predetermined price. Key details of the issue include:

• Issue Size: Up to 2,03,88,000 fully paid-up equity shares
• Issue Price: ₹10 per share
• Rights Entitlement Ratio: 2:1 (Two new shares for every one share held)
• Record Date: October 3, 2025
• Issue Opening Date: October 30, 2025
• Issue Closing Date: November 10, 2025

Financial Impact

The rights issue is set to have a significant impact on UH Zaveri's share structure:

*Assuming full subscription

Issue Schedule and Process

The company has outlined the following schedule for the rights issue:

• Last Date for Credit of Rights Entitlements: October 27, 2025
• Last Date for On-Market Renunciation: November 4, 2025

Shareholders will be able to trade their rights entitlements on the stock exchange during this period. The International Securities Identification Number (ISIN) for the dematerialized Rights Entitlement is INE556Z20010.

Management Statement

Hitesh Mahendrakumar Shah, Managing Director of UH Zaveri Limited, signed off on the official communication to the BSE, detailing the outcome of the board meeting and the terms of the rights issue.

Investor Considerations

This rights issue presents an opportunity for existing shareholders to increase their stake in the company at a predetermined price. However, investors should carefully review the Letter of Offer, which contains detailed terms and conditions of the issue, before making any investment decisions.

The success of this rights issue could significantly bolster UH Zaveri's financial position, potentially providing the company with additional capital for future growth initiatives or debt reduction, depending on the stated use of proceeds in the offer document.

As always, investors are advised to conduct their own research and consult with financial advisors before participating in any securities offering.